Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
M's Bridge
New York, New York, USAmebs.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Bridge Medicines is a pioneering drug discovery company that advances promising early technologies from concept to clinic. It extends the work of the Tri-Institutional Therapeutics Discovery Institute—a collaborative venture between Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, and Takeda Pharmaceutical Company Ltd.—to develop innovative breakthrough science into clinically and commercially valuable drug products. The pipeline spans approximately 50 early-stage projects across multiple therapeutic areas including infectious disease, oncology, neurology, and rare diseases.
- Therapeutic areas
- OncologyRare DiseasesNeurologyInfectious Diseases
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
Memorial Sloan Kettering Cancer CenterThe Rockefeller UniversityWeill Cornell MedicineTakeda Pharmaceutical Company Ltd.Deerfield ManagementBay City Capital
Beyond the preview
Go deeper on M's Bridge.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on M's Bridge.